Clinical Trials on Diabetes Mellitus Type 2 in Austria

Total 911 results

Medical University of Vienna

Unknown

Study to Develop a Kinetic Model for FDG and Me4FDG in Kidneys of Type 2 Diabetic Patients

Type2 Diabetes Mellitus

Austria
Landsteiner Institut
Medical University of Vienna; Lund University Hospital; Mein Hanusch-Krankenhaus and other collaborators

Completed

Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic Humans (RECO1)

Type 2 Diabetes Mellitus

Austria
Landsteiner Institut
Lund University; Medical University of Vienna; Mein Hanusch-Krankenhaus; Fondazione... and other collaborators

Completed

Effects of Six Months of Moderate Resistance- Versus Endurance-Training on Muscle ATP Synthesis in First-Degree Relatives of Patients With Type 2 Diabetes (RECO2)

Type 2 Diabetes Mellitus | Insulin Resistance

Austria
Medical University of Graz

Completed

Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes (PROLOG)

Healthy | Obesity | Type 2 Diabetes Mellitus | Type 1 Diabetes

Austria
Paracelsus Medical University

Completed

Secondary Prevention in Type 2 Diabetes: Comparison of Two Different Resistance Exercise Training Protocols

Type 2 Diabetes Mellitus

Austria
CeQur Corporation
International Diabetes Center at Park Nicollet

Completed

Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
CeQur Corporation

Terminated

A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
Metronom Health
Medical University of Graz

Unknown

Metronom Continuous Glucose Monitoring System

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabete Mellitus

Austria, Denmark
Medical University of Vienna

Completed

Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin (LixiBIT)

Type 2 Diabetes Mellitus

Austria
CeQur Corporation

Completed

A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
Medical University of Graz

Completed

Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients

Hyperglycemia | Diabetes Mellitus Type 2

Austria
Ionis Pharmaceuticals, Inc.

Completed

Study to Evaluate the Effect of ISIS GCGRRx on Hepatic Lipid and Glycogen Content in Type 2 Diabetes

Type 2 Diabetes

Austria
University of Vienna

Unknown

Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB) (MIKRODIAB)

Cancer | Type 2 Diabetes

Austria
MetaCure Limited

Unknown

The DIAMOND® for the Treatment of Type 2 Diabetes

Type 2 Diabetes

Australia, Austria, Greece, Italy, Poland, Serbia
German Diabetes Center

Completed

Phielix et al.: Hepatic Fat Content and Adipokines

Type 2 Diabetes Mellitus

Austria
Medical University of Vienna
National Bank of Austria

Unknown

Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus (Tele-Diab)

Insulin Resistance | Diabetes Mellitus Type 2

Austria
Medical University of Graz

Completed

Efficacy, Usability Study of the GlucoTab System for Glycaemic Management in Type 2 Diabetic Patients at General Wards

Type 2 Diabetes

Austria
Medical University of Graz

Completed

Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management

Type 2 Diabetes

Austria
Medical University of Vienna

Unknown

Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects

Type 2 Diabetes Mellitus | Endothelial Dysfunction | Cardiovascular Risk

Austria
Landeskrankenanstalten-Betriebsgesellschaft
European Commission

Completed

Medium-term Health Coaching and Life-long Monitoring in Diabetes Mellitus (RenewingHealth)

Diabetes Mellitus Type 2

Austria
Hoffmann-La Roche

Completed

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Type 2 Diabetes, Type 1 Diabetes

Austria, United Kingdom
University of Adelaide
Salk Institute for Biological Studies; University of South Australia

Completed

Time RestrIcted Feeding For Improving Diabetes Risk (TRIFFID) (TRIFFID)

Obesity | Type2 Diabetes

Australia
AstraZeneca
Bristol-Myers Squibb

Completed

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Type 2 Diabetes Mellitus (T2DM)

United States
Medical University of Graz

Completed

The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines (TNF4)

Obesity | Type 2 Diabetes Mellitus

Austria
Medical University of Vienna

Completed

The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes (HYPOTESIS)

Type 2 Diabetes

Austria
Medical University of Graz

Completed

EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes

Austria
Paracelsus Medical University

Completed

Exercise Training Improves Coronary Endothelial Dysfunction in Diabetes Mellitus Type 2 and Coronary Artery Disease

Coronary Artery Disease | Type 2 Diabetes Mellitus

Austria
Monash University
University of Victoria; University of Auckland, New Zealand

Completed

Can Vitamin D Supplementation Prevent Type 2 Diabetes?

Type 2 Diabetes Mellitus

Australia
Solvay Pharmaceuticals

Completed

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

Patients With Type 2 Diabetes

Australia
Garvan Institute of Medical Research
Weizmann Institute of Science

Active, not recruiting

Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes (PREDICT)

Type 2 Diabetes Mellitus | Pre Diabetes

Australia
Medical University of Graz

Completed

Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responders (CARDIONOR)

Diabetes Mellitus, Type II

Austria
Medical University of Vienna

Completed

Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements

Diabetes Mellitus Type II

Austria
AstraZeneca
Eli Lilly and Company

Completed

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Italy, Korea, Republic of, Hungary, Canada, Australia
Medical University of Vienna
AstraZeneca

Completed

Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. (EXENDA)

Type2 Diabetes | Steatosis, Liver

Austria
HighTide Biopharma Pty Ltd

Completed

Study of HTD4010 in Healthy Volunteers

Type 2 Diabetes Mellitus

Australia
QL Biopharmaceutical Australia Pty Ltd
Novotech (Australia) Pty Limited; Beijing QL Biopharmaceutical Co.,Ltd

Recruiting

A Study of ZT002 in Healthy Participants

Type 2 Diabetes Mellitus

Australia
Hoffmann-La Roche

Completed

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Diabetes Mellitus Type 2

Austria, Germany, United States
Mesoblast, Ltd.

Completed

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

Diabetic Nephropathy | Type 2 Diabetes

Australia
Eli Lilly and Company

Completed

A Study for Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Brazil, Canada, Mexico, India, Australia, China, Korea, Republic of
Medtronic Diabetes

Completed

Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics

Type 1 Diabetes Mellitus | Type2 Diabetes Mellitus

United States
Medical University of Vienna

Unknown

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations (RISC_7T)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Healthy Volunteers | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Familiar Hypocalcuric Hypercalcemia

Austria
Carmot Therapeutics, Inc.
Carmot Australia First Pty Ltd

Recruiting

A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus

Diabetes

Australia, Mexico
Menzies Institute for Medical Research

Recruiting

Metabolic Benefits of Drinking Blueberry Tea in Type 2 Diabetes

Type 2 Diabetes

Australia
AstraZeneca
Eli Lilly and Company

Completed

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

Type 2 Diabetes Mellitus

Italy, Poland, Hungary, Mexico, Greece, Australia
AstraZeneca

Completed

Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered

Type 2 Diabetes Mellitus

United States
Bristol-Myers Squibb

Completed

Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)

Diabetes

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca
Bristol-Myers Squibb

Terminated

Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects

Type 2 Diabetes Mellitus

United States

3

Subscribe